Protein fibrillation and the olfactory system: speculations on their linkage

Trends in Biotechnology

Volumn 30, Issue 12, 2012, Pages 609-610

  Mahmoudi, Morteza ^a,b   Suslick, Kenneth S ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; CATION; METAL ION; METALLOPROTEIN; NANOPARTICLE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN FUNCTION; COGNITION; DISEASE COURSE; EARLY DIAGNOSIS; FRONTOTEMPORAL DEMENTIA; HUMAN; LETTER; LEWY BODY; MOUSE; NANOTECHNOLOGY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FIBRILLATION; PROTEIN FOLDING;

ALZHEIMER DISEASE; AMYLOID; ANIMALS; HUMANS; MICE; MODELS, MOLECULAR; OLFACTORY PATHWAYS; PROTEINS;

EID: 84869117826     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2012.08.007     Document Type: Letter

References (11)

1. Dobson C.M. Protein folding and misfolding. Nature 2003, 426:884.
2. Frederickson C.J., et al. The neurobiology of zinc in health and disease. Nat. Rev. Neurosci. 2005, 6:449.
3. Laurent S., et al. Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease. RSC Adv. 2012, 2:5008-5033.
4. Wesson D.W., et al. Should olfactory dysfunction be used as a biomarker of Alzheimer's disease?. Expert Rev. Neurother. 2010, 10:633-635.
5. Peters J.M., et al. Olfactory function in mild cognitive impairment and Alzheimer's disease: an investigation using psychophysical and electrophysiological techniques. Am. J. Psychiatry 2003, 160:1995-2002.
6. Wesson D.W., et al. Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model. J. Neurosci. 2010, 30:505-514.
7. Williams S.S., et al. Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. J. Neurol. Neurosurg. Psychiatry 2009, 80:667-670.
8. Wang J., et al. Is the olfactory receptor a metalloprotein?. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3035-3039.
9. Lippard S.J., Berg J.M. Principles of Bioinorganic Chemistry 1994, University Science Books.
10. Anzellotti A.I., Farrell N.P. Zinc metalloproteins as medicinal targets. Chem. Soc. Rev. 2008, 37:1629-1651.
11. Whittell G.R., et al. Functional soft materials from metallopolymers and metallosupramolecular polymers. Nat. Mater. 2011, 10:176-188.